Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

ClinicalTrials.gov ID: NCT02815267

Public ClinicalTrials.gov record NCT02815267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3 study to evaluate the efficacy, safety and long-term safety of the topical administration of FMX-101, 4% minocycline foam for the treatment of moderate-to-severe acne vulgaris.

Study identification

NCT ID
NCT02815267
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vyne Therapeutics Inc.
Industry
Enrollment
466 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2016 (Actual)
Primary completion
Oct 13, 2017 (Actual)
Completion
Oct 13, 2017 (Actual)
Last update posted
Jan 18, 2022

2016 – 2017

United States locations

U.S. sites
30
U.S. states
22
U.S. cities
28
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205 —
Not listed Fremont California 94538 —
Not listed Fullerton California 92835 —
Not listed Shelton Connecticut 06484 —
Not listed Washington D.C. District of Columbia 20037 —
Not listed Boynton Beach Florida 33437 —
Not listed Miami Florida 33015 —
Not listed Miami Florida 33174 —
Not listed Miramar Florida 33027 —
Not listed Sanford Florida 32771 —
Not listed Savannah Georgia 31406 —
Not listed Oakbrook Terrace Illinois 60181 —
Not listed Evansville Indiana 47713 —
Not listed Metairie Louisiana 70006 —
Not listed Rockville Maryland 20850 —
Not listed Bay City Michigan 48706 —
Not listed Omaha Nebraska 68114 —
Not listed Las Vegas Nevada 89117 —
Not listed New York New York 10012 —
Not listed New York New York 10075 —
Not listed High Point North Carolina 27262 —
Not listed Columbus Ohio 43213 —
Not listed Gresham Oregon 97030 —
Not listed Johnston Rhode Island 02919 —
Not listed Murfreesboro Tennessee 37130 —
Not listed Dallas Texas 75234 —
Not listed Plano Texas 75024 —
Not listed San Antonio Texas 78229 —
Not listed West Jordan Utah 84088 —
Not listed Bridgeport West Virginia 26330 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02815267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02815267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →